A word in your ear: the 2004 Annals of Oncology prizes
The international quality requirements for the conduct of clinical studies and the challenges for study centers to implement them
Adjuvant therapy for stage II colon cancer: an elephant in the living room?
Prognostic relevance of cell proliferation in head and neck tumors
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study
A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
Safety of sentinel node biopsy in pregnant patients with breast cancer
Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
Thromboembolism following removal of femoral venous apheresis catheters in patients with breast cancer
BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
Identifying subgroups among poor prognosis patients with nonseminomatous germ cell cancer by tree modelling: a validation study
The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma
Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma
Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index
Trends in cancer mortality in the European Union and accession countries, 1980–2000
Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy
Topotecan versus paclitaxel in second-line therapy: a lost opportunity for quality-of-life evaluation?
Topotecan versus paclitaxel in second-line therapy: a lost opportunity for quality-of-life evaluation?
Cyclooxygenase-2 inhibitor and cisplatin combination as a radiosensitizer in the treatment of head and neck cancer patients
Complete disappearance of multiple periorbital xanthelasmata after chemotherapy for primary extragonadal germ-cell mediastinal tumor
Acute neurotoxicity as a serious adverse event related to rasburicase in a non-Hodgkin's lymphoma patient